S2Medical AB (publ) (STO:S2M)

S2Medical AB Statistics

Total Valuation

S2Medical AB has a market cap or net worth of SEK 8.98 million. The enterprise value is 8.07 million.

Market Cap	8.98M
Enterprise Value	8.07M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

S2Medical AB has 906.78 million shares outstanding. The number of shares has increased by 53.03% in one year.

Current Share Class	898.66M
Shares Outstanding	906.78M
Shares Change (YoY)	+53.03%
Shares Change (QoQ)	+2.96%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.56
PB Ratio	0.91
P/TBV Ratio	1.11
P/FCF Ratio	n/a
P/OCF Ratio	13.30
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.80
EV / Sales	0.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.56

Current Ratio	0.56
Quick Ratio	0.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-443.67

Financial Efficiency

Return on equity (ROE) is -70.59% and return on invested capital (ROIC) is -11.64%.

Return on Equity (ROE)	-70.59%
Return on Assets (ROA)	-7.90%
Return on Invested Capital (ROIC)	-11.64%
Return on Capital Employed (ROCE)	-26.95%
Weighted Average Cost of Capital (WACC)	20.07%
Revenue Per Employee	2.30M
Profits Per Employee	-1.44M
Employee Count	7
Asset Turnover	0.77
Inventory Turnover	1.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.00% in the last 52 weeks. The beta is 2.88, so S2Medical AB's price volatility has been higher than the market average.

Beta (5Y)	2.88
52-Week Price Change	-1.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	44.89
Average Volume (20 Days)	4,470,513

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, S2Medical AB had revenue of SEK 16.13 million and -10.09 million in losses. Loss per share was -0.01.

Revenue	16.13M
Gross Profit	14.04M
Operating Income	-2.66M
Pretax Income	-10.09M
Net Income	-10.09M
EBITDA	-1.39M
EBIT	-2.66M
Loss Per Share	-0.01

Balance Sheet

The company has 907,000 in cash and n/a in debt, with a net cash position of 907,000 or 0.00 per share.

Cash & Cash Equivalents	907,000
Total Debt	n/a
Net Cash	907,000
Net Cash Per Share	0.00
Equity (Book Value)	9.88M
Book Value Per Share	0.01
Working Capital	-3.06M

Cash Flow

Operating Cash Flow	675,000
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 87.07%, with operating and profit margins of -16.50% and -62.57%.

Gross Margin	87.07%
Operating Margin	-16.50%
Pretax Margin	-62.57%
Profit Margin	-62.57%
EBITDA Margin	-8.59%
EBIT Margin	-16.50%
FCF Margin	n/a

Dividends & Yields

S2Medical AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.03%
Shareholder Yield	-53.03%
Earnings Yield	-112.42%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

S2Medical AB has an Altman Z-Score of -8.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.32
Piotroski F-Score	3